Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-Egfr Affibody
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2020.00176
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 4, 2020
Authors
Publisher
Frontiers Media SA